• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口服给药后,浓度依赖性蛋白结合对丙吡胺及其代谢物血清浓度和尿排泄的影响。

Influence of concentration-dependent protein binding on serum concentrations and urinary excretion of disopyramide and its metabolite following oral administration.

作者信息

Haughey D B, Lima J J

出版信息

Biopharm Drug Dispos. 1983 Apr-Jun;4(2):103-12. doi: 10.1002/bdd.2510040202.

DOI:10.1002/bdd.2510040202
PMID:6882879
Abstract

Concentrations of disopyramide (D) and mono-N-dealkyldisopyramide (MND) were measured in serum and urine following administration of 100, 150, 200, and 300 mg D to four volunteers. The free fraction of D in serum was drug concentration-dependent in all four subjects following the administration of the four doses. Areas under the free (unbound) D serum concentration-time curves (AUC free 0-9) were linearly related to dose following 100-200 mg D. AUC free 0-9 values were 30-60 per cent higher than expected in two subjects following 300 mg D due to an apparent dose-dependent decrease in D renal tubular secretion. Renal clearance of free D averaged 10.9 1 h-1. The renal clearance of MND averaged 10.3 1 h-1. The urinary excretion of MND was proportional to disopyramide dose.

摘要

给四名志愿者分别服用100、150、200和300毫克丙吡胺(D)后,测定其血清和尿液中丙吡胺(D)和单-N-去烷基丙吡胺(MND)的浓度。在给予四剂药物后,所有四名受试者血清中D的游离分数均呈药物浓度依赖性。在给予100-200毫克D后,游离(未结合)D血清浓度-时间曲线下面积(AUC游离0-9)与剂量呈线性相关。由于D肾小管分泌明显的剂量依赖性降低,在两名受试者给予300毫克D后,AUC游离0-9值比预期高30%-60%。游离D的肾清除率平均为10.9升/小时。MND的肾清除率平均为10.3升/小时。MND的尿排泄量与丙吡胺剂量成正比。

相似文献

1
Influence of concentration-dependent protein binding on serum concentrations and urinary excretion of disopyramide and its metabolite following oral administration.口服给药后,浓度依赖性蛋白结合对丙吡胺及其代谢物血清浓度和尿排泄的影响。
Biopharm Drug Dispos. 1983 Apr-Jun;4(2):103-12. doi: 10.1002/bdd.2510040202.
2
The effects of urine pH and plasma protein binding on the renal clearance of disopyramide.尿液pH值和血浆蛋白结合对丙吡胺肾清除率的影响。
Clin Pharmacokinet. 1977 Sep-Oct;2(5):373-83. doi: 10.2165/00003088-197702050-00004.
3
Plasma binding of disopyramide and mono-N-dealkyldisopyramide.丙吡胺及单-N-去烷基丙吡胺的血浆结合情况。
Br J Clin Pharmacol. 1982 Nov;14(5):673-6. doi: 10.1111/j.1365-2125.1982.tb04955.x.
4
The pharmacokinetics of disopyramide and mono-N-dealkyl-disopyramide in humans.丙吡胺和单-N-脱烷基丙吡胺在人体内的药代动力学。
Int J Clin Pharmacol Ther Toxicol. 1982 May;20(5):219-26.
5
The effect of saturable binding to plasma proteins on the pharmacokinetic properties of disopyramide.与血浆蛋白的饱和结合对丙吡胺药代动力学特性的影响。
J Pharmacokinet Biopharm. 1982 Feb;10(1):1-14. doi: 10.1007/BF01059180.
6
Disopyramide pharmacokinetics and bioavailability following the simultaneous administration of disopyramide and 14C-disopyramide.同时给予丙吡胺和14C-丙吡胺后丙吡胺的药代动力学和生物利用度。
J Pharmacokinet Biopharm. 1984 Jun;12(3):289-313. doi: 10.1007/BF01061722.
7
Stereoselective pharmacokinetics of disopyramide enantiomers in man.丙吡胺对映体在人体中的立体选择性药代动力学。
Drug Metab Dispos. 1985 Sep-Oct;13(5):572-7.
8
Disopyramide concentrations in saliva.唾液中的丙吡胺浓度。
Int J Clin Pharmacol Ther Toxicol. 1982 Feb;20(2):68-72.
9
The influence of protein binding on disopyramide clearance.蛋白结合对丙吡胺清除率的影响。
Eur J Clin Pharmacol. 1982;23(5):453-6. doi: 10.1007/BF00605997.
10
Disopyramide serum and pharmacologic effect kinetics applied to the assessment of bioavailability.丙吡胺血清及药理效应动力学在生物利用度评估中的应用。
Br J Clin Pharmacol. 1978 Nov;6(5):409-19. doi: 10.1111/j.1365-2125.1978.tb04605.x.

引用本文的文献

1
Disopyramide pharmacokinetics and bioavailability following the simultaneous administration of disopyramide and 14C-disopyramide.同时给予丙吡胺和14C-丙吡胺后丙吡胺的药代动力学和生物利用度。
J Pharmacokinet Biopharm. 1984 Jun;12(3):289-313. doi: 10.1007/BF01061722.
2
Clinical pharmacokinetics of disopyramide.丙吡胺的临床药代动力学。
Clin Pharmacokinet. 1986 May-Jun;11(3):214-22. doi: 10.2165/00003088-198611030-00003.
3
Practical optimisation of antiarrhythmic drug therapy using pharmacokinetic principles.运用药代动力学原理对抗心律失常药物治疗进行实际优化。
Clin Pharmacokinet. 1991 Feb;20(2):151-66. doi: 10.2165/00003088-199120020-00006.